— Among patients with deadly cancers, more than 90 percent die because of metastatic spread of their disease. Gelman, Ph.D., of Roswell Park Cancer Institute (RPCI) has identified a new suppressor of cancer metastasis that may point the way toward development of more effective treatments for prostate cancers and other malignant solid tumors.
READ FULL ARTICLE
From Newswise